Chemoimmunotherapy Before Surgery Lets Some Head and Neck Cancer Patients Skip High-Dose Radiation
A phase II trial found that preoperative chemo-immunotherapy with sintilimab achieved major pathological responses in 59.1 percent of locally advanced ...
